RESTORE-IMI 1: a multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections - Motsch, J; Murta de Oliveira, C; Stus, V (Clin Infect Dis, 2020)